Gene: COG5
Official Full Name: component of oligomeric golgi complex 5provided by HGNC
Gene Summary: The protein encoded by this gene is one of eight proteins (Cog1-8) which form a Golgi-localized complex (COG) required for normal Golgi morphology and function. The encoded protein is organized with conserved oligomeric Golgi complex components 6, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants. Mutations in this gene result in congenital disorder of glycosylation type 2I.[provided by RefSeq, Jan 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31843 | COG5 Knockout cell line (HeLa) | Human | COG5 | 1:3~1:6 | Negative | Online Inquiry |
KO31844 | COG5 Knockout cell line (HCT 116) | Human | COG5 | 1:2~1:4 | Negative | Online Inquiry |
KO31845 | COG5 Knockout cell line (HEK293) | Human | COG5 | 1:3~1:6 | Negative | Online Inquiry |
KO31846 | COG5 Knockout cell line (A549) | Human | COG5 | 1:3~1:4 | Negative | Online Inquiry |
COG5 Gene Knockout Cell Lines are specialized cellular models created through targeted genome editing to disable the COG5 gene, which plays a critical role in the processes of glycosylation and intracellular trafficking. These cell lines facilitate the study of COG5's function in post-translational modifications and cellular processes, particularly in the context of congenital disorders of glycosylation and diseases linked to aberrated protein glycosylation.
Key functions of COG5 Gene Knockout Cell Lines include the ability to elucidate the biological pathways impacted by COG5 deficiency. By knocking out this gene, researchers can investigate the downstream effects on the glycosylation of proteins, explore mechanisms of cellular stress responses, and assess the subsequent impact on cellular morphology and function. This not only enhances our understanding of the biological role of COG5 but also aids in identifying potential therapeutic targets for diseases caused by defective glycosylation.
The scientific importance of these knockouts is underscored by their applications in both basic research and clinical settings. They serve as a vital tool for pharmaceutical companies and academic institutions focused on drug discovery and development, enabling comparative studies that could lead to the discovery of novel treatments for glycosylation disorders. Furthermore, they are instrumental in high-throughput screening processes to evaluate the efficacy of compounds targeting COG5-related pathways.
What sets our COG5 Gene Knockout Cell Lines apart from alternatives is their proven consistency in knockdown efficacy and cellular behavior, supported by rigorous validation experiments. This reliability allows researchers to draw accurate conclusions from their experiments without the typical variability associated with less-validated cell models.
We understand the challenges researchers and clinicians face in creating effective experimental models, and our COG5 Gene Knockout Cell Lines provide a streamlined solution that enhances experimental fidelity and reproducibility. With our commitment to quality and innovation, we are dedicated to helping the scientific community unlock the insights necessary for advancing knowledge and therapeutic strategies in the realm of gene function and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.